Matches in SemOpenAlex for { <https://semopenalex.org/work/W4321461811> ?p ?o ?g. }
Showing items 1 to 100 of
100
with 100 items per page.
- W4321461811 endingPage "8" @default.
- W4321461811 startingPage "8" @default.
- W4321461811 abstract "Background: Blood loss of postoperative after prostate surgery could be related with an increase in urinary fibrinolytic activity. Tranexamic acid (TXA) is both a potent inhibitor of plasminogen and urokinase activators and a low molecular weight substance that is excreted unchanged in the urinary tract and can be administered both orally and intravenously. This study aimed to evaluate the effectiveness TXA administration in reducing bleeding in benign prostatic hyperplasia (BPH) patients who underwent open prostatectomy. Materials and Methods: This double-blind randomized clinical trial was conducted on patients with BPH who underwent open prostatectomy. The first group received TXA (1 gr IV from during surgery to 48 h after surgery, 3 times/day). Twenty-four hours after surgery, the two groups were compared in terms of bleeding rate. Hemoglobin (Hb), hematocrit (HCT), and platelet (Plt) counts were also assessed before and after the intervention. Results: Intervention and control groups were comparable in terms of basic and baseline values of variables at the beginning of the study (P > 0.05). The mean bleeding volume in TXA group was significantly lower than the control group 112.11 ± 53.5 and 190.00 ± 97.5 CC; P ≤ 0.001). Mean hospitalization (3.28±0.46 vs. 4.38 ± 0.95 days P < 0.001) and surgery duration (98.11 ± 37.11 vs. 128.00 ± 39.12 h; P = 0.001) were significantly lower in TXA group compared to control intervention. Conclusion: According to the findings of the current study, the administration of TXA led to reduce bleeding in BPH patients who underwent open prostatectomy. Furthermore, the mean Hb, HCT, levels were significantly affected by TXA. TXA treatment approach also can reduce the surgery and hospitalization time effectively. TXA approach is recommended as effective procedure in BPH patients who underwent open prostatectomy." @default.
- W4321461811 created "2023-02-22" @default.
- W4321461811 creator A5006137041 @default.
- W4321461811 creator A5031599508 @default.
- W4321461811 creator A5051565529 @default.
- W4321461811 creator A5061565251 @default.
- W4321461811 creator A5065338217 @default.
- W4321461811 creator A5065890084 @default.
- W4321461811 creator A5069692503 @default.
- W4321461811 creator A5071654036 @default.
- W4321461811 creator A5089828159 @default.
- W4321461811 date "2023-01-01" @default.
- W4321461811 modified "2023-10-14" @default.
- W4321461811 title "Evaluating the effectiveness of tranexamic acid administration in reducing bleeding in benign prostate hyperplasia patients underwent open prostatectomy: A double-blind randomized clinical trial" @default.
- W4321461811 cites W1643426278 @default.
- W4321461811 cites W1981196689 @default.
- W4321461811 cites W1988910337 @default.
- W4321461811 cites W2068265929 @default.
- W4321461811 cites W2080546217 @default.
- W4321461811 cites W2089922909 @default.
- W4321461811 cites W2162741181 @default.
- W4321461811 cites W2517412921 @default.
- W4321461811 cites W2736564516 @default.
- W4321461811 cites W2741308486 @default.
- W4321461811 cites W2802014225 @default.
- W4321461811 cites W2808807768 @default.
- W4321461811 cites W2902957663 @default.
- W4321461811 cites W2932075562 @default.
- W4321461811 cites W2974885539 @default.
- W4321461811 cites W2987123986 @default.
- W4321461811 cites W4211144482 @default.
- W4321461811 cites W4251855550 @default.
- W4321461811 cites W2209833516 @default.
- W4321461811 doi "https://doi.org/10.4103/jrms.jrms_308_22" @default.
- W4321461811 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36974110" @default.
- W4321461811 hasPublicationYear "2023" @default.
- W4321461811 type Work @default.
- W4321461811 citedByCount "1" @default.
- W4321461811 countsByYear W43214618112023 @default.
- W4321461811 crossrefType "journal-article" @default.
- W4321461811 hasAuthorship W4321461811A5006137041 @default.
- W4321461811 hasAuthorship W4321461811A5031599508 @default.
- W4321461811 hasAuthorship W4321461811A5051565529 @default.
- W4321461811 hasAuthorship W4321461811A5061565251 @default.
- W4321461811 hasAuthorship W4321461811A5065338217 @default.
- W4321461811 hasAuthorship W4321461811A5065890084 @default.
- W4321461811 hasAuthorship W4321461811A5069692503 @default.
- W4321461811 hasAuthorship W4321461811A5071654036 @default.
- W4321461811 hasAuthorship W4321461811A5089828159 @default.
- W4321461811 hasBestOaLocation W43214618111 @default.
- W4321461811 hasConcept C121608353 @default.
- W4321461811 hasConcept C126322002 @default.
- W4321461811 hasConcept C126894567 @default.
- W4321461811 hasConcept C141071460 @default.
- W4321461811 hasConcept C168563851 @default.
- W4321461811 hasConcept C2776235491 @default.
- W4321461811 hasConcept C2777562237 @default.
- W4321461811 hasConcept C2779466945 @default.
- W4321461811 hasConcept C2779478474 @default.
- W4321461811 hasConcept C2779637338 @default.
- W4321461811 hasConcept C2780959883 @default.
- W4321461811 hasConcept C2991743468 @default.
- W4321461811 hasConcept C71924100 @default.
- W4321461811 hasConcept C77411442 @default.
- W4321461811 hasConceptScore W4321461811C121608353 @default.
- W4321461811 hasConceptScore W4321461811C126322002 @default.
- W4321461811 hasConceptScore W4321461811C126894567 @default.
- W4321461811 hasConceptScore W4321461811C141071460 @default.
- W4321461811 hasConceptScore W4321461811C168563851 @default.
- W4321461811 hasConceptScore W4321461811C2776235491 @default.
- W4321461811 hasConceptScore W4321461811C2777562237 @default.
- W4321461811 hasConceptScore W4321461811C2779466945 @default.
- W4321461811 hasConceptScore W4321461811C2779478474 @default.
- W4321461811 hasConceptScore W4321461811C2779637338 @default.
- W4321461811 hasConceptScore W4321461811C2780959883 @default.
- W4321461811 hasConceptScore W4321461811C2991743468 @default.
- W4321461811 hasConceptScore W4321461811C71924100 @default.
- W4321461811 hasConceptScore W4321461811C77411442 @default.
- W4321461811 hasIssue "1" @default.
- W4321461811 hasLocation W43214618111 @default.
- W4321461811 hasLocation W43214618112 @default.
- W4321461811 hasLocation W43214618113 @default.
- W4321461811 hasOpenAccess W4321461811 @default.
- W4321461811 hasPrimaryLocation W43214618111 @default.
- W4321461811 hasRelatedWork W1978630268 @default.
- W4321461811 hasRelatedWork W2013357874 @default.
- W4321461811 hasRelatedWork W2330542927 @default.
- W4321461811 hasRelatedWork W2414475439 @default.
- W4321461811 hasRelatedWork W2563901765 @default.
- W4321461811 hasRelatedWork W2743741616 @default.
- W4321461811 hasRelatedWork W2979366738 @default.
- W4321461811 hasRelatedWork W3175503089 @default.
- W4321461811 hasRelatedWork W3204428142 @default.
- W4321461811 hasRelatedWork W4281763909 @default.
- W4321461811 hasVolume "28" @default.
- W4321461811 isParatext "false" @default.
- W4321461811 isRetracted "false" @default.
- W4321461811 workType "article" @default.